Eric Eugene Esser - Apr 17, 2024 Form 4 Insider Report for Telesis Bio Inc. (TBIO)

Role
President & CEO, Director
Signature
/s/ Rob Cutler, as Attorney-in-Fact
Stock symbol
TBIO
Transactions as of
Apr 17, 2024
Transactions value $
$0
Form type
4
Date filed
4/19/2024, 05:08 PM
Previous filing
Mar 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction TBIO Common Stock +Grant/Award $0 +100,000 +341.76% $0.00 129,260 Apr 17, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TBIO Stock Option (right to buy) +Grant/Award $0 +200,000 $0.00 200,000 Apr 17, 2024 Common Stock 200,000 $0.38 Direct F2

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. Subject to the Reporting Person's continuing as a Service Provider (as defined in the Issuer's 2021 Stock Incentive Plan (the "Plan")) through each applicable vesting date, 50% of the RSUs shall vest on April 17, 2025, and the remaining 50% of the RSUs shall vest on April 17, 2026.
F2 Subject to the Reporting Person's continuing as a Service Provider (as defined in the Plan) through each applicable vesting date, 25% of the shares subject to the option shall vest on April 17, 2025, and 1/36th of the remaining shares subject to the option shall vest each month thereafter.